OptimizeRx Corp. (OPRX) Stock Analysis & Investment Frameworks
OptimizeRx Corp. (OPRX) stock analysis on Invetso. Review OptimizeRx Corp.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
OptimizeRx Corp. Company Overview
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Medical - Healthcare Information Services
- Country: US
OptimizeRx Corp. Key Financial Metrics
- Market Cap: $175.74M
- Revenue: $109.43M
- P/E Ratio: 34.56
- ROE: 3.60%
- ROIC: 4.91%
- Dividend Yield: N/A
About OptimizeRx Corp.
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.
OptimizeRx Corp. Investment Frameworks
Invetso analyzes OptimizeRx Corp. (OPRX) across the following frameworks:
- OptimizeRx Corp. 10Y Growth Potential
- OptimizeRx Corp. Scenario Analysis
- OptimizeRx Corp. Risks & Opportunities
- OptimizeRx Corp. Economic Moat
- OptimizeRx Corp. Business Model
- OptimizeRx Corp. Management
- OptimizeRx Corp. SWOT Analysis
- OptimizeRx Corp. Porter's 5 Forces
- OptimizeRx Corp. PESTLE Analysis
- OptimizeRx Corp. ESG Analysis